NFKB1 and COVID-19: In summary, we speculate that SG can regulate the NF-κB signaling pathway, inhibit the release of pro-inflammatory factors such as IL-6, and slow down the occurrence of a cytokine storm, thereby exerting a therapeutic effect on COVID-19.